Seeking Alpha

Big Pharma lobbies Australia to extend poppy growing

  • GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) and TPI Enterprises want the government of Australia to let them grow poppies on the country's mainland, due to a shortage of opium for pain killers and amid soaring demand.
  • Australia only allows poppy growing in Tasmania, which is responsible for around half of the world's supply of opiate-based pain relief. Recent drought and storms in Tasmania have meant that drug firms can't get enough crops.
Comments (4)
  • Van Hyder
    , contributor
    Comments (162) | Send Message
    Can't get enough crop, that's going to hurt.
    11 Mar, 09:26 AM Reply Like
  • pmiller100
    , contributor
    Comments (353) | Send Message
    The U.S. military is destroying poppy fields in Afghanistan. Maybe they ought to harvest instead of burn. They could funnel the product to big pharma, who presumably won't make it into Heroin, and return some proceeds to the local farmers who might appreciate something rather than just a scorched field.
    11 Mar, 09:30 AM Reply Like
  • jumpnjoey77
    , contributor
    Comments (468) | Send Message
    The Afghan stuff is more potent too.
    11 Mar, 09:37 AM Reply Like
  • pmiller100
    , contributor
    Comments (353) | Send Message
    And you know that how exactly? Lol, just kidding.
    12 Mar, 08:12 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: